Skip to content

Is this SDAX stock experiencing a significant surge of 24%? Could this upward trend continue further?

Stock price of CompuGroup surges 24% due to acquisition speculation by CVC, proposing 22€ per share deal.

Rapid Ascent of SDAX Stock: Up by 24%, but Does It Hold More Gains?
Rapid Ascent of SDAX Stock: Up by 24%, but Does It Hold More Gains?

Is this SDAX stock experiencing a significant surge of 24%? Could this upward trend continue further?

Check out these unexpected surge!

Hey there! Guess what's going down today – shares for medical software provider, Compugroup, are blowing up with a jaw-dropping 24% rise! But what's causing this medical marvel? Could there be more in store for lucky investors? Let's dive in!

Compugroup stock: Higher, higher!

On Monday, Compugroup, known for serving up software to medical practices and hospitals, saw a massive +24% surge. The secret sauce? Takeover whispers!

Word on the street is that financial investor CVC is in talks to make a move, and the Gotthardt shareholder group has confirmed it. The game plan? To delist Compugroup from the stock exchange once the deal's done – setting a price of 22 euros per share. Just yesterday, the stock was trading at around 16 euros. The success of the takeover depends on the involvement of anchor shareholders.

More to savor?

Pre-market trading saw a mouthwatering +24% rise in shares, hitting 21 euros, but it's since cooled off. The dream 22 euros course is still within reach, but investors should steer clear of speculation. After all, the road to success may still have some twists and turns ahead. Even a later delisting offer might not mean a higher price.

Pro Tip: BOERSE ONLINE has had its eye on Compugroup for some time now, considering the stock a juicy takeover target. Read all about it right here.

Extra servings:

12 steaming-hot stock leaps: Analysts can't get enough of these tickers

  • Sources:
  • Takeover talks with Compugroup Medical indicate delisting date of June 24, 2025.
  • No specific pending takeover negotiations reported beyond delisting for Compugroup Medical.
  • Takeover talks for Gerresheimer remain uncertain with no definite timeline or imminent public bid.
  • Some partnered bids for Gerresheimer, like the joint bid by KPS Capital Partners and Warburg Pincus, have fallen through, suggesting dwindling investor interest.

Investors might find this intriguing: The current surge in Compugroup's stock price reveals potential opportunities in finance and investing, particularly in the stock-market, as takeover whispers indicate a possible delisting, with a potential price of 22 euros per share. However, it's essential to exercise caution, as the road to completion may still have twists and turns ahead, and the success of the takeover depends on the involvement of anchor shareholders.

Read also:

    Latest